Aerie Pharmaceuticals Inc Revenue per Employee (AERI), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket
 


Aerie Pharmaceuticals Inc   (NASDAQ: AERI)
 

Aerie Pharmaceuticals Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 23.25% in the third quarter 2022, year on year to cumulative value of $214 million, Aerie Pharmaceuticals Inc 's revenue per employee grew on a trailing twelve months basis to $ 826,027, this marks a new company high.
Within the Healthcare sector Employees of 43 other companies have achieved higher revenue per employee. While Aerie Pharmaceuticals Inc 's total ranking has deteriorated compared to the previous quarter from 0 to 733. Aerie Pharmaceuticals Inc has 259 employees.


What is Sales per Employee Ratio?







AERI Revenue per Employee (Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Revenue Change 23.25 % 22.53 % 29.89 % 364.55 % 45.97 %
Sales per Employee (TTM) $ 826,027 799,710 776,058 749,552 402,127
AERI's Total Ranking # 733 # 0 # 0 # 0 # 0
Seq. Revenue Change 8.46 % 11.65 % -73.98 % 291.18 % 7.83 %


Revenue per Employee Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 9
Healthcare Sector # 44
Overall Market # 733

Revenue per Employee Statistics
High Average Low
$ 826,027 $ 442,983 $ 187,046
(Sep 30 2022)   (Jun 30 2019)



Financial Statements
Aerie Pharmaceuticals Inc 's Revenue MRQ $ 36 Millions Visit AERI's Income Statement
Aerie Pharmaceuticals Inc 's Revenues TTM $ 214 Millions Visit AERI's aggregate revenue growth
What are AERI's Sales? Visit AERI's Sales by Segment




Other Ratios
Aerie Pharmaceuticals Inc 's Income per Employee
Employees in Biotechnology & Pharmaceuticals
Biotechnology & Pharmaceuticals Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
AERI's Revenue per Employee versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for AERI's Competitors
Revenue per Employee for AERI's Suppliers
Revenue per Employee for AERI's Customers

You may also want to know
AERI's Sales Growth Rates AERI's Pe Price to earnings ratio AERI's Receivables Turnover Ratio AERI's Stock Quote
AERI's Net Income Growth Rates AERI's Ps Price to Sales ratio AERI's Sales per Employee AERI's Asset Turnover Ratio
AERI's Net Margin AERI's Pb Price to Book ratio AERI's Financial Strength Ratios AERI's Dividend Payout Ratio
Date modified: 2026-08-29T17:18:16+00:00




Companies with similar Revenue per Employee for 12 months ending Sep 30 2022, within Healthcare Sector Revenue per Employee Revenue 12 months ending Sep 30 2022Number of Employees Sep 30 2022
Petros Pharmaceuticals inc   1,442,289.33 $ 4.327  Million
Bristol myers Squibb Company  1,438,092.31 $ 46,738.000  Million 32,500 
Exelixis Inc   1,428,321.71 $ 1,638.285  Million 1,147 
Ispecimen inc   1,427,120.86 $ 9.990  Million
Marker Therapeutics inc   1,389,222.20 $ 6.946  Million
Biogen Inc   1,381,760.00 $ 10,363.200  Million 7,500 
Halozyme Therapeutics Inc   1,372,631.21 $ 580.623  Million 423 
Harmony Biosciences Holdings inc   1,367,781.57 $ 400.760  Million 293 
Aytu Biopharma Inc  1,347,723.68 $ 102.427  Million 76 
Pfizer Inc  1,329,013.33 $ 99,676.000  Million 75,000 
United Therapeutics Corporation  1,328,571.43 $ 1,860.000  Million 1,400 
Journey Medical Corp  1,296,896.55 $ 75.220  Million 58 
Regenxbio Inc   1,293,892.18 $ 480.034  Million 371 
Alector Inc   1,292,922.33 $ 133.171  Million 103 
Ginkgo Bioworks Holdings Inc   1,269,377.32 $ 615.648  Million 485 
Alpine Immune Sciences Inc   1,268,160.00 $ 31.704  Million 25 
Jazz Pharmaceuticals Plc  1,240,132.18 $ 3,583.982  Million 2,890 
Acorda Therapeutics Inc   1,216,313.73 $ 124.064  Million 102 
Puma Biotechnology Inc   1,216,273.74 $ 217.713  Million 179 
Kineta Inc   1,211,250.00 $ 4.845  Million
Paragon 28 inc   1,198,958.33 $ 172.650  Million 144 
Lipocine Inc   1,186,523.79 $ 16.611  Million 14 
Collegium Pharmaceutical Inc   1,174,491.73 $ 496.810  Million 423 
Incyte Corporation  1,171,163.15 $ 3,330.788  Million 2,844 
Exicure Inc   1,146,250.00 $ 9.170  Million
Scienture Holdings Inc   1,143,869.56 $ 10.295  Million
Xencor Inc  1,142,250.00 $ 296.985  Million 260 
Integrated Biopharma Inc  1,116,420.00 $ 55.821  Million 50 
Myovant Sciences Ltd   1,114,792.64 $ 333.323  Million 299 
Agenus Inc  1,109,888.89 $ 89.901  Million 81 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.